Pharmacological blockade of MPO activity also attenuated tissue injury and promoted resolution in murine models of pleurisy [167], immune complex vasculitis [144], and chronic obstructive pulmonary disease [138]. The gene discussed is MPO; the disease is chronic obstructive pulmonary disease.